Menopause and metabolic dysfunction-associated steatotic liver disease
Maturitas,
Journal Year:
2024,
Volume and Issue:
186, P. 108024 - 108024
Published: May 14, 2024
Language: Английский
Excess cardiovascular mortality in men with non-alcoholic fatty liver disease: A cause for concern!
World Journal of Cardiology,
Journal Year:
2024,
Volume and Issue:
16(7), P. 380 - 384
Published: July 24, 2024
Non-alcoholic
fatty
liver
disease
(NAFLD)
has
emerged
as
the
commonest
cause
of
chronic
worldwide
in
recent
years.
With
time,
our
understanding
NAFLD
evolved
from
an
isolated
condition
to
a
systemic
with
significant
manifestations
beyond
liver.
Amongst
them,
cardiovascular
diseases
(CVDs)
are
most
important
and
clinically
relevant.
Recent
research
supports
strong
independent
link
between
NALFD
CVD
shared
risk
factors
pathophysiology.
Female
sex
hormones
well
known
not
only
protect
against
pre-menopausal
females,
but
also
contribute
improved
adipose
tissue
function
preventing
its
deposition.
highlights
increased
major
adverse
cardiovascular-cerebral
events
(MACCE)
amongst
male
compared
females.
Further,
racial
variation
was
observed
MACCE
outcomes
NAFLD,
excess
mortality
Native
Americans
Asian
Pacific
Islanders
other
races.
Language: Английский
Role of plasma metabolome in mediating the effect of plasma lipidome on NAFLD: a Mendelian randomization study
Zhuyuan Zheng,
No information about this author
Shaojie Yang,
No information about this author
Wanlin Dai
No information about this author
et al.
Frontiers in Endocrinology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 23, 2025
Background
This
study
explored
the
causal
connection
among
plasma
lipidome,
nonalcoholic
fatty
liver
disease
(NAFLD),
and
potential
metabolome
mediators
through
Mendelian
randomization
(MR).
Methods
We
obtained
summary
statistics
for
179
lipidome
traits
(
N
=
7,174),
1,400
8,299),
one
NAFLD
trait
from
publicly
available
genome-wide
association
studies.
A
two-sample
MR
analysis
was
conducted
to
infer
causality.
Additionally,
multiple
sensitivity
analyses
were
assess
heterogeneity,
horizontal
pleiotropy,
robustness
of
findings.
MetaboAnalyst
6.0
used
pathway
identified
lipids
metabolites.
Furthermore,
we
mediation
whether
effect
on
mediated
by
metabolome.
Results
The
predicted
a
genetically
determined
relationship
between
lipidomes
NAFLD.
No
compelling
proof
found
that
influenced
risk
five
mentioned
earlier.
Based
established
relationships
metabolites,
eight
metabolic
pathways
are
closely
associated
with
Our
revealed
six
relationships,
indicating
specific
pleiotropy
in
analysis.
Conclusions
In
summary,
our
lipidomes,
metabolomes,
Certainly,
impact
is
not
limited
need
further
investigate
into
other
possible
mediators.
These
factors
may
become
new
biomarkers
contributing
its
prevention,
diagnosis,
treatment.
Language: Английский